Return to program book search

Session Information

SYM S026 - Common, Challenging and Controversial Short Topics in Patient Management

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Saturday, March 22

CME Credits: 3.00

Location: Room 108/110/112

Time: 2:00 PM - 5:00 PM

Director: Michael E. Bigby, MD, FAAD - Handout

Speakers:
  • Scott Andrew Buckta Collins, MD, FAAD - Handout
  • Boni E. Elewski, MD, FAAD - Handout
  • Mark Lebwohl, MD, FAAD - Handout
  • Catalin Popescu, MD - Handout
  • Su-Jean Seo, MD, PhD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Explore common, yet challenging, or controversial, patient-management issues routinely faced by practicing dermatologists.
  • Receive evidence-based answers to clinically relevant questions encountered in everyday practice.

Description:
This forum is designed to provide evidence-based answers to common, yet challenging or controversial, patient-management problems. Topics chosen reflect illnesses commonly seen by practicing dermatologists. There is one moderator and five presenters. Each presenter has 20 minutes to address two to four questions. Answers to questions should be concise and evidence based. There will be 10-minutes of questions, answers or discussion immediately following each presentation. The format is extremely fast-paced. There is no time for introductory material by the moderator or the presenters. The moderator is charged with keeping the session on time.

References:

  • Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, Bowman M. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004 Jan-Feb;17(1):59-67. PubMed PMID: 15014055.

Schedule:

Saturday, March 22
2:00 PMHow Should the risks of depression, suicide or inflammatory bowel disease be managed for patients treated with isotretinoin? / Dr. Popescu
2:30 PMWhen is it appropriate to use Mohs surgery? Is Mohs surgery being over utilized? / Dr. Collins
3:00 PMWhat are the cure rates and relapse rates with terbinafine, itraconazole or fluconazole? Should we be treating onychomycosis with lasers? / Dr. Elewski
3:30 PMWhat are the effects of topical treatments commonly used to treat molluscum or warts? / Dr. Bigby
4:00 PMShould actinic keratoses be treated? What are the effects of available field treatments for actinic keratoses? / Dr. Lebwohl
4:30 PMDiscussion / All faculty